Short-term senolytic treatment: a paradigm to promote fracture repair during aging
Open accessThe DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Abstract
Increased age is blamed for a wide range of bone physiological changes, and although the underlying mechanisms affecting the decreased capacity for fracture healing are not fully understood, they are clearly linked to changes at the cellular level. Recent evidence suggests potential roles of senescent cells in response to most tissue injuries, including bone fractures. In this issue of the JCI, Liu, Zhang, and co-authors showed that a senolytic drug cocktail cleared senescent cells from the callus and improved bone fracture repair in aged mice. Understanding how senescent cells emerge at fracture sites and how their timely removal improves fracture healing should provide insights for effective therapeutic approaches in old age.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Cellular senescence is a driver of both physiologically beneficial phenotypes and age-related pathologies owing to the heterogeneous phenotypes of senescent cells that inhabit an organism or tissue, i.e., “senotype,” which is dependent on biological context and environmental factors.”
From Connecting aging biology and inflammation in the omics era (2022) · cites this paper as [52]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“the ML-defined senescent populations were enriched for other senescence signatures,12–18 although with some lineage-specific disparities for some lists (Figure 4G)”
From SenCat: Cataloging human cell senescence through multi-omic profiling of multiple senescent primary cell types (2026) · cites this paper as [12]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cellular senescence: from physiology to pathology
Muñoz-Espín, D., & Serrano, M. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3823 · Cited by 2,818
An Essential Role for Senescent Cells in Optimal Wound Healing through Secretion of PDGF-AA
Demaria, M., Ohtani, N., Youssef, S. A., Rodier, F., Toussaint, W., Mitchell, J. R., Laberge, R.-M., Vijg, J., Van Steeg, H., Dollé, M. E. T., et al. (2014) · Developmental Cell · doi:10.1016/j.devcel.2014.11.012 · Cited by 2,045
A proteomic atlas of senescence-associated secretomes for aging biomarker development
Basisty, N., Kale, A., Jeon, O. H., Kuehnemann, C., Payne, T., Rao, C., Holtz, A., Shah, S., Sharma, V., Ferrucci, L., et al. (2020) · PLOS Biology · doi:10.1371/journal.pbio.3000599 · Cited by 1,348
Self-citationDai, X.-M., Ryan, G. R., Hapel, A. J., Dominguez, M. G., Russell, R. G., Kapp, S., Sylvestre, V., & Stanley, E. R. (2002) · Blood · doi:10.1182/blood.v99.1.111 · Cited by 1,184
Unmasking Transcriptional Heterogeneity in Senescent Cells
Hernandez-Segura, A., de Jong, T. V., Melov, S., Guryev, V., Campisi, J., & Demaria, M. (2017) · Current Biology · doi:10.1016/j.cub.2017.07.033 · Cited by 972
Risk of Mortality Following Clinical Fractures
Cauley, J. A., Thompson, D. E., Ensrud, K. C., Scott, J. C., & Black, D. (2000) · Osteoporosis International · doi:10.1007/s001980070075 · Cited by 947 · cited 1×
“The skeletal system is particularly affected by increasing age, raising the impact of osteoporosis and osteoarthritis and leading to higher rates of bone fractures with delayed healing that are associated with temporal incapacitation and, ultimately, increased morbidity and mortality (1).”
BackgroundMacrophages in bone fracture healing: Their essential role in endochondral ossification
Schlundt, C., El Khassawna, T., Serra, A., Dienelt, A., Wendler, S., Schell, H., van Rooijen, N., Radbruch, A., Lucius, R., Hartmann, S., et al. (2018) · Bone · doi:10.1016/j.bone.2015.10.019 · Cited by 615
Hall, B. M., Balan, V., Gleiberman, A. S., Strom, E., Krasnov, P., Virtuoso, L. P., Rydkina, E., Vujcic, S., Balan, K., Gitlin, I. I., et al. (2017) · Aging · doi:10.18632/aging.101268 · Cited by 407
The senescence-associated secretome as an indicator of age and medical risk
Schafer, M. J., Zhang, X., Kumar, A., Atkinson, E. J., Zhu, Y., Jachim, S., Mazula, D. L., Brown, A. K., Berning, M., Aversa, Z., et al. (2020) · JCI Insight · doi:10.1172/jci.insight.133668 · Cited by 401
Transcriptome signature of cellular senescence
Casella, G., Munk, R., Kim, K. M., Piao, Y., De, S., Abdelmohsen, K., & Gorospe, M. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz555 · Cited by 359
Cited by
Connecting aging biology and inflammation in the omics era
Walker, K. A., Basisty, N., Wilson, D. M., & Ferrucci, L. (2022) · Journal of Clinical Investigation · doi:10.1172/jci158448 · Cited by 189
“Achieving senotype specificity, or tailoring senolytics to harmful subsets of senescent cells while sparing potentially beneficial ones, presents a challenge to be addressed by future generations of senolytics (51, 52).”
BackgroundSelf-citationPan, C. C., Maeso‐Díaz, R., Lewis, T. R., Xiang, K., Tan, L., Liang, Y., Wang, L., Yang, F., Yin, T., Wang, C., et al. (2023) · Cell Research · doi:10.1038/s41422-023-00820-4 · Cited by 20
The Roles of Myeloid Cells in Aging-related Liver Diseases
Yao, J., Li, Y., & Wang, H. (2023) · International Journal of Biological Sciences · doi:10.7150/ijbs.82352 · Cited by 18
“In preclinical models, senolytics prevent or alleviate cardiovascular [151], liver [119], lung [152], kidney disorders [153] as well as complications of organ transplantation [154], age-dependent fracture healing [155] and disc degeneration [156].”
BackgroundTranslating Senotherapeutic Interventions into the Clinic with Emerging Proteomic Technologies
Dey, A. K., Banarjee, R., Boroumand, M., Rutherford, D. V., Strassheim, Q., Nyunt, T., Olinger, B., & Basisty, N. (2023) · Biology · doi:10.3390/biology12101301 · Cited by 14
“Two common classes of pharmacological senotherapeutics include senolytics and senomorphics [9,10].”
BackgroundSelf-citationAnerillas, C., Altés, G., Gresova, K., Tsitsipatis, D., Mazan-Mamczarz, K., Banarjee, R., Cunningham, A. S. G., Salamini-Montemurri, M., Yang, J.-H., Munk, R., et al. (2026) · Molecular Cell · doi:10.1016/j.molcel.2026.05.017 · Cited by 11
Self-citation
Metadata
- Authors
- Beerman, I., Basisty, N., & de Cabo, R.
- Affiliations
- National Institutes of Health (US)
- Venue
- Journal of Clinical Investigation
- Published
- 2022-04-15
- Volume
- 132
- Issue
- 8
- ISSN
- 0021-9738 (ISSN-L)
- 1558-8238
- PMC
- PMC9012278
- OpenAlex
- W4223909560
- Cited by
- 15
- References
- 22
- Citations by year
- 2026: 6 · 2025: 3 · 2024: 1 · 2023: 3 · 2022: 2
- FWCI
- 1.39
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Journal of Clinical Investigation (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Office of Dietary Supplements
- National Institutes of Health
- National Institute on Aging
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone fractures and treatments
- Keywords
- senolytics, cellular senescence, fracture healing, aging, callus, age-related bone loss
- MeSH terms
- Aging, Animals, Bony Callus, Fracture Healing, Fractures, Bone, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Short-term senolytic treatment: a paradigm to promote fracture repair during aging. https://app.cochat.ai/papers/10.1172/jci158871
- The paper
- Beerman, I., Basisty, N., & de Cabo, R. (2022). Short-term senolytic treatment: a paradigm to promote fracture repair during aging. Journal of Clinical Investigation. https://doi.org/10.1172/jci158871
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.